247 related articles for article (PubMed ID: 33758106)
21. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
22. Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma.
Li H; Yang LL; Wu CC; Xiao Y; Mao L; Chen L; Zhang WF; Sun ZJ
Am J Clin Pathol; 2020 Apr; 153(5):618-629. PubMed ID: 31977029
[TBL] [Abstract][Full Text] [Related]
23. A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.
Wu ZH; Tang Y; Zhou Y
Mediators Inflamm; 2020; 2020():6716908. PubMed ID: 33456371
[TBL] [Abstract][Full Text] [Related]
24. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L
J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
26. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma.
Liu G; Zheng J; Zhuang L; Lv Y; Zhu G; Pi L; Wang J; Chen C; Li Z; Liu J; Chen L; Cai G; Zhang X
Sci Rep; 2018 Oct; 8(1):15250. PubMed ID: 30323196
[TBL] [Abstract][Full Text] [Related]
27. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.
Wang M; Jiang F; Wei K; Wang J; Zhou G; Wu C; Yin G
Technol Cancer Res Treat; 2021; 20():15330338211004936. PubMed ID: 33910445
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
[TBL] [Abstract][Full Text] [Related]
30. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
31. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma.
Du W; Xia X; Gou Q; Xie Y; Gao L
Asian J Surg; 2024 May; 47(5):2106-2121. PubMed ID: 38320907
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
Wu ZH; Fang M; Zhou Y
PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
Xin W; Zhao C; Jiang L; Pei D; Zhao L; Zhang C
Pathol Oncol Res; 2021; 27():585192. PubMed ID: 34257533
[TBL] [Abstract][Full Text] [Related]
35. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
36. Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma.
Duan X; Cheng X; Yin X; Ke Z; Song J
Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1535-1547. PubMed ID: 34218307
[TBL] [Abstract][Full Text] [Related]
37. Prognostic association of starvation-induced gene expression in head and neck cancer.
Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N
Sci Rep; 2021 Sep; 11(1):19130. PubMed ID: 34580365
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
40. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
Qin X; Liu Z; Yan K; Fang Z; Fan Y
Int J Med Sci; 2021; 18(4):953-963. PubMed ID: 33456353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
